Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -44.50% is 34% below its 5-year average of -33.31%, around the middle of its 5-year range (-85.65%–-10.70%).
As of the fiscal period ended Tuesday, June 30, 2026. 114.98% below its 12-month average of -20.70%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -44.50%.
RETURN ON EQUITY (ROE)
-44.50%
RETURN ON EQUITY (ROE) AVG TTM
-20.70%
RETURN ON EQUITY (ROE) AVG 3Y
-33.06%
RETURN ON EQUITY (ROE) AVG 5Y
-33.31%
RETURN ON EQUITY (ROE) AVG 10Y
-42.29%
RETURN ON EQUITY (ROE) AVG 15Y
-36.61%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-114.98%
CURRENT VS 3Y AVG
-34.59%
CURRENT VS 5Y AVG
-33.58%
CURRENT VS 10Y AVG
-5.23%
CURRENT VS 15Y AVG
-21.54%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-5.92%
vs the sector median at left
Grace Therapeutics, Inc.
Market Cap
$34.26M
Return on Equity (ROE)
-44.50%
TTM Avg
-20.70%
3Y Avg
-33.06%
5Y Avg
-33.31%
Market Cap
$33.63M
Return on Equity (ROE)
N/A
TTM Avg
105.22%
3Y Avg
53.02%
5Y Avg
47.52%
Market Cap
$31.37M
Return on Equity (ROE)
-86.96%
TTM Avg
-27.78%
3Y Avg
5.60%
5Y Avg
57.54%
Market Cap
$34.49M
Return on Equity (ROE)
329.02%
TTM Avg
154.76%
3Y Avg
265.18%
5Y Avg
128.71%
Market Cap
$33.34M
Return on Equity (ROE)
-248.21%
TTM Avg
-991.58%
3Y Avg
-655.25%
5Y Avg
-438.62%
Market Cap
$33.21M
Return on Equity (ROE)
-117.97%
TTM Avg
-59.96%
3Y Avg
-42.92%
5Y Avg
-31.82%
Market Cap
$32.92M
Return on Equity (ROE)
-238.24%
TTM Avg
203.84%
3Y Avg
55.01%
5Y Avg
16.87%
Market Cap
$34.97M
Return on Equity (ROE)
-154.06%
TTM Avg
-1.75%
3Y Avg
68.54%
5Y Avg
60.27%
Market Cap
$35.29M
Return on Equity (ROE)
-161.63%
TTM Avg
-60.21%
3Y Avg
-26.37%
5Y Avg
-20.13%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $34.26M | -44.50% | -20.70% | -33.06% | -33.31% |
| Scilex Holding Company (SCLX)vs › | $33.63M | N/A | 105.22% | 53.02% | 47.52% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.37M | -86.96% | -27.78% | 5.60% | 57.54% |
| Elutia Inc (ELUT)vs › | $34.49M | 329.02% | 154.76% | 265.18% | 128.71% |
| HeartBeam, Inc. (BEAT)vs › | $33.34M | -248.21% | -991.58% | -655.25% | -438.62% |
| Accuray Incorporated (ARAY)vs › | $33.21M | -117.97% | -59.96% | -42.92% | -31.82% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $32.92M | -238.24% | 203.84% | 55.01% | 16.87% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | -154.06% | -1.75% | 68.54% | 60.27% |
| DocGo Inc. (DCGO)vs › | $35.29M | -161.63% | -60.21% | -26.37% | -20.13% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.46M | -476.77% | -979.99% | -646.46% | -421.61% |
ROE
-44.5%
ROA
-42.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -44.50% |
| 2026-03-31 | -14.12% |
| 2025-12-31 | -10.70% |
| 2025-09-30 | -15.50% |
| 2025-06-30 | -18.67% |
| 2025-03-31 | -18.14% |
| 2024-12-31 | -33.15% |
| 2024-09-30 | -25.79% |
| 2024-06-30 | -26.07% |
| 2024-03-31 | -27.90% |
| 2023-12-31 | -80.82% |
| 2023-09-30 | -81.40% |
| 2023-06-30 | -85.65% |
| 2023-03-31 | -81.41% |
| 2022-12-31 | -21.56% |
| 2022-09-30 | -20.41% |
| 2022-06-30 | -13.67% |
| 2022-03-31 | -11.36% |
| 2021-12-31 | -13.06% |
| 2021-09-30 | -12.09% |
| 2021-06-30 | -43.57% |
| 2021-03-31 | -46.18% |
| 2020-12-31 | -5.07% |
| 2020-09-30 | -73.51% |
| 2020-06-30 | -129.88% |
| 2020-03-31 | -26.39% |
| 2019-03-31 | -366.02% |
| 2018-12-31 | -152.61% |
| 2018-06-30 | -360.30% |
| 2018-03-31 | -264.74% |
| 2016-11-30 | -50.66% |
| 2016-08-31 | -42.44% |
| 2016-05-31 | -33.97% |
| 2016-02-29 | -24.12% |
| 2015-11-30 | -25.10% |
| 2015-08-31 | -3.06% |
| 2015-05-31 | -14.24% |
| 2015-02-28 | -5.65% |
| 2014-11-30 | -5.19% |
| 2014-08-31 | -26.26% |
| 2014-05-31 | -22.96% |
| 2014-02-28 | -36.61% |
| 2013-11-30 | -54.25% |
| 2013-08-31 | -40.90% |
| 2013-05-31 | -89.47% |
| 2013-02-28 | -71.72% |
| 2012-11-30 | -59.58% |
| 2012-08-31 | -57.07% |
| 2012-05-31 | -56.56% |
| 2012-02-29 | -45.86% |
| 2011-11-30 | -46.81% |
| 2011-08-31 | -57.60% |
| 2011-05-31 | -35.52% |
| 2011-02-28 | -45.74% |
| 2010-02-28 | -36.26% |
